Cosmetic companies are required to submit facility registration and product listing information on cosmetic products that they manufacture, or other procedures, including manipulation, sampling, testing, or control procedures applied to the product.
While there is a number of items that are required to be reported to FDA, FDA has yet to put forth the system to handle such facility registrations and product listings.
For products marketed that is marketed on December 29, 2022, the company must submit a cosmetic product listing not later than December 29, 2023.
Important FDA Guidance for Cosmetic Companies – new facility registration and product listing.
View referenced article
Author(s)
Related Insights
October 2, 2026
Foley Viewpoints
An Early Look at Q3 2026 PE Activity
As we enter the final quarter of 2026, it’s time to look back at private equity (PE) activity last quarter and what that might tell us as we move into the final stretch of 2026. PitchBook has released their Q3 2026 Global PE First Look, taking an early look at global and US PE data last quarter. In a nutshell, some large-scale transactions led to a rebound in global PE exit activity in Q3, but that comes alongside a drop in fundraising activity.
September 25, 2026
Foley Viewpoints
Control capital for growth. Where venture ends and buyouts begin.
It’s Wednesday and another edition of The Growth Docket. What does “growth equity” mean for me: it’s where venture capital meets private equity.
September 25, 2026
Labor & Employment Law Perspectives
How To Improve Hiring Transparency Amid Ghost Job Scrutiny
Imagine a job seeker who has spent weeks tailoring applications, paying for a premium subscription on a major hiring platform and refreshing listings every morning, only to discover that many of the positions were never real. The listings were ghost jobs — postings for roles that do not exist or are not actively being filled. It sounds like a bad dream, but the problem is well documented.